Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Apr 2021 for Impel Neuropharma INC, €1.3M.
Filing timeline
BuySaleKKR Iris Investors LLC
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
KKR Iris Investors LLC: trading record in brief
All filings by KKR Iris Investors LLC on record concern Impel Neuropharma Inc. We count 3 filings, every one of them for a trade on 27 April 2021.
Purchases make up the whole of the open-market record (1 purchase, €13.6M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 29 April 2021 came the latest disclosure, a transaction for €1.3M in Impel Neuropharma Inc. The most recent open-market purchase was published on 29 April 2021, 2,003 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to KKR Iris Investors LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
118,712 shares@ US$13.508.9% of flowCommon StockSEC:0001140361-21-014994:1
1,100,000 shares@ US$15.0091.1% of flowCommon StockSEC:0001140361-21-014994:2
Canonical exit: 26 Jul 2021 (T+90)
2,583,926 sharesCommon StockSEC:0001140361-21-014994:0
3 of 3 declarations
